X

Quality Statement

Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety.

X

Image Use Agreement

By downloading, copying, or making any use of the images located on this website (“Site”) you acknowledge that you have read and understand, and agree to, the terms of this Image Usage Agreement, as well as the terms provided on the Legal Notices webpage, which together govern your use of the images as provided below. If you do not agree to such terms, do not download, copy or use the images in any way, unless you have written permission signed by an authorized Pacific Biosciences representative.

Subject to the terms of this Agreement and the terms provided on the Legal Notices webpage (to the extent they do not conflict with the terms of this Agreement), you may use the images on the Site solely for (a) editorial use by press and/or industry analysts, (b) in connection with a normal, peer-reviewed, scientific publication, book or presentation, or the like. You may not alter or modify any image, in whole or in part, for any reason. You may not use any image in a manner that misrepresents the associated Pacific Biosciences product, service or technology or any associated characteristics, data, or properties thereof. You also may not use any image in a manner that denotes some representation or warranty (express, implied or statutory) from Pacific Biosciences of the product, service or technology. The rights granted by this Agreement are personal to you and are not transferable by you to another party.

You, and not Pacific Biosciences, are responsible for your use of the images. You acknowledge and agree that any misuse of the images or breach of this Agreement will cause Pacific Biosciences irreparable harm. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. You must include any copyright notice originally included with the images on all copies.

IMAGES ARE PROVIDED BY Pacific Biosciences ON AN "AS-IS" BASIS. Pacific Biosciences DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, NON-INFRINGEMENT, OWNERSHIP, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL Pacific Biosciences BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE IMAGES.

You agree that Pacific Biosciences may terminate your access to and use of the images located on the PacificBiosciences.com website at any time and without prior notice, if it considers you to have violated any of the terms of this Image Use Agreement. You agree to indemnify, defend and hold harmless Pacific Biosciences, its officers, directors, employees, agents, licensors, suppliers and any third party information providers to the Site from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of the terms of this Image Use Agreement or Pacific Biosciences' termination of your access to or use of the Site. Termination will not affect Pacific Biosciences' rights or your obligations which accrued before the termination.

I have read and understand, and agree to, the Image Usage Agreement.

I disagree and would like to return to the Pacific Biosciences home page.

Pacific Biosciences
Contact:

More Than 115 Presentations and Posters Feature PacBio SMRT Sequencing to Decipher Complex Plant and Animal Genomes at Annual PAG Conference

Thursday, January 12, 2017

MENLO PARK, Calif., Jan. 12, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced that its Single Molecule, Real-Time (SMRT®) Sequencing technology will be featured in at least 57 podium presentations and 60 posters at the International Plant & Animal Genome (PAG) XXV Conference  taking place January 14-18 in San Diego, California.  From specialty beverage crops like hops and cabernet sauvignon grapes
to economically and societally important livestock like cattle, goat, and pig, more than 60 new plant and animal genome assemblies generated with PacBio data will be presented at this year’s conference.

“Each year at PAG, we are delighted to see the increasing adoption of SMRT Sequencing and the number of new species benefiting from the highly accurate, uniform long-read data provided by our systems,” said Kevin Corcoran, Senior Vice President of Market Development for Pacific Biosciences. “This year we will see some of the first genome assemblies produced with the SequelTM System, as well as demonstrations of the growing interest in our Iso-SeqTM method for genome annotation.”         

PacBio will host a workshop in the afternoon of January 16 with speakers from the company and prominent researchers from diverse fields. Topics will cover both conservation genomics and agrigenomics, as well as the fight against Zika and other mosquito vector-based diseases. Dr. Richard Kuo from the Roslin
Institute
will present a chicken genome annotation, including Iso-Seq data from the Sequel System. Rod Wing from the Arizona Genomics Institute will present a new rice genome assembly generated entirely with Sequel data, as well as some early data for another strain using the recently released 2.0 chemistry. PacBio’s Chief Scientific Officer Dr. Jonas Korlach will report on the new chemistry and software updates.

PacBio is
seeing strong growth in agbio, and growing adoption in fields outside of agriculture, such as a number of new projects in conservation biology. Dr. Erich Jarvis, Professor at the Rockefeller University, co-founder of the B10K project and co-leader of the G10K initiative, recently purchased multiple Sequel Systems to support their goal of creating de novo assemblies for a large number of vertebrate species. He will be speaking about his research at the PacBio workshop. Rebecca Johnson,
Director of the Australian Museum Research Institute, will be giving a plenary lecture on genomics for wildlife conservation, which will include discussion of a new high-quality koala reference genome assembled de novo with SMRT Sequencing, which will be featured in-depth at the PacBio workshop.

Other PacBio activities include a SMRT Informatics Developers Conference on January 18, expert hours educational programming, and an exhibition booth (#418). In conjunction with PAG, PacBio is hosting its fourth annual SMRT Grant program. The most interesting genome or transcriptome proposal received by January 31 will receive free SMRT Sequencing on the Sequel System.

About Pacific Biosciences

Pacific Biosciences of California, Inc. (NASDAQ:PACB) offers sequencing systems to help scientists resolve genetically complex problems. Based on its novel Single Molecule, Real-Time (SMRT®) technology, Pacific Biosciences’ products enable: de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript
analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms in important gene families, and find novel genes; targeted sequencing to more comprehensively characterize genetic variations; and real-time kinetic information for epigenome characterization. Pacific Biosciences’ technology provides high accuracy, ultra-long reads, uniform coverage, and is the only DNA sequencing technology that provides the ability to simultaneously detect epigenetic changes. PacBio® sequencing systems, including consumables and software, provide a simple, fast, end-to-end workflow for SMRT Sequencing. More information is available at www.pacb.com.

Forward-Looking Statements

All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to future availability, market adoption, uses, quality or performance of, or benefits of using, products or technologies, and other future events. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, changes in circumstances and other factors that are, in some cases, beyond Pacific Biosciences’ control and could cause actual
results to differ materially from the information expressed or implied by forward-looking statements made in this press release. Factors that could materially affect actual results can be found in Pacific Biosciences’ most recent filings with the Securities and Exchange Commission, including Pacific Biosciences’ most recent reports on Forms 8-K, 10-K and 10-Q, and include those listed under the caption “Risk Factors.”

Pacific Biosciences undertakes no obligation to revise or update information in this press release to reflect events or circumstances in the future, even if new information becomes available.

Contacts



Media:

Nicole Litchfield

415.793.6468

nicole@bioscribe.com



Investors:

Trevin Rard

650.521.8450

ir@pacificbiosciences.com

Primary Logo

Source: Pacific Biosciences, Inc.

News Provided by Acquire Media

Press Release

Pacific Biosciences Announces New Chief Financial Officer

Monday, September 14, 2020

Stay
Current

Visit our blog »